R.R. GAFUROVA¹, R.M. FAYZULLINA¹, G.U. MAKAROVA², M.S. STARTSEVA²

¹Bashkir State Medical University, Ufa

²Republican Children’s Clinical Hospital, Ufa

 Contact details:

Gafurova R.R. — post-graduate student of the Department of Faculty Pediatrics with courses in Pediatrics and Neonatology and Simulation Center

Address: 3 Lenin St., Ufa, Russian Federation, 450008, tel.: +7-937-332-33-32, e-mail: rita.gafurova2017@yandex.ru

Stevens — Johnson syndrome is a rare severe acute systemic allergic reaction. Most often, this reaction is induced in children by an exposure to pathogenic microorganisms and intake of medications, mainly occurring with damage to the skin and mucous membranes of at least two organs. Despite the fact that the disease is rare in pediatric practice, its relevance is due not only to the fact that children with Stevens-Johnson syndrome have a sharply increased risk of complications and death, but also to the fact that today there are no universal regulatory algorithms and standards for the management of such patients. The diagnosis verification is based on the clinical symptoms of the disease and a competently collected anamnesis. Unfortunately, the current polypragmasia, as well as the difficulties of differentiating between the symptoms manifested in Stevens-Johnson syndrome, which are often regarded by doctors as the debut of an acute respiratory disease, complicates the interpretation of the disease inducer and leads to a late diagnosis, which in turn delays the elimination of allergen and therapy, eventually affecting the course and outcome of pathology. The article describes a clinical case in a patient with first-time Stevens — Johnson syndrome in response to the combined effects of such etiological factors as primary cytomegalovirus infection and drug administration. The patient was managed in a hospital setting with differential diagnosis and the appointment of intensive and rational therapy, which led to a favorable outcome of the disease.

Key words: Stevens — Johnson syndrome, children, polypragmasia, erythema exsudativum multiforme.

REFERENCES

1. Lepekhova A.A., Allenova A.S., Olisova O.Yu., Teplyuk N.P., Kanareykina E.V. Comparative evaluation of the effectiveness of various methods of therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis based on literature data. Vestnik Rossiyskoy akademii meditsinskikh nauk, 2019,  vol. 74, no. 37,  pp. 157–166 (in Russ.).
2. Singh S., Jakati S., Shanbhag S.S., Elhusseiny A.M., Djalilian A.R., Basu S. Lid margin keratinization in Stevens — Johnson syndrome: Review of pathophysiology and histopathology. Ocul Surf, 2021,  vol. 21,  pp. 299–305.
3. Kryuger E.A., Rymarenko N.V., Bobrysheva A.V. Stevens-Johnson syndrome in children — a look at the problem. Tavricheskiy mediko-biologicheskiy vestnik, 2020,  vol. 23, no. 3,  pp. 78–85 (in Russ.).
4. Bardenikova S.I., Pen’tkovskaya O.S., Isaeva E.K. Stevens-Johnson syndrome is an immune catastrophe. RMZh. Mat’ i ditya, 2019,  vol. 2, no. 1,  pp. 66–72 (in Russ.).
5. Soyuz pediatrov Rossii. Federal’nye klinicheskie rekomendatsii po okazaniyu pomoshchi detyam s mnogoformnoy ekssudativnoy eritemoy i toksikodermiey [Union of Pediatricians of Russia. Federal clinical guidelines for the care of children with erythema multiforme exudative and toxicoderma], 2015. 25 p., available at: https://dgb.cherepovets.ru/wp-content/uploads/2017/04/5.MEE-toksikodermiya.pdf
6. Grünwald P., Mockenhaupt M., Panzer R., Emmert S. Erythema multiforme, Stevens — Johnson syndrome/toxic epidermal necrolysis — diagnosis and treatment // J Dtsch Dermatol Ges. — Vol. 18 (6). — Р. 547–553.